Short Interest in INVO Fertility, Inc (NASDAQ:IVF) Expands By 281.1%

INVO Fertility, Inc (NASDAQ:IVF) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totaling 94,554 shares, a growth of 281.1% from the November 30th total of 24,811 shares. Based on an average daily volume of 982,155 shares, the short-interest ratio is currently 0.1 days. Currently, 4.0% of the shares of the stock are short sold. Currently, 4.0% of the shares of the stock are short sold. Based on an average daily volume of 982,155 shares, the short-interest ratio is currently 0.1 days.

Hedge Funds Weigh In On INVO Fertility

An institutional investor recently bought a new position in INVO Fertility stock. Citadel Advisors LLC bought a new position in shares of INVO Fertility, Inc (NASDAQ:IVF) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 66,849 shares of the company’s stock, valued at approximately $51,000. Citadel Advisors LLC owned about 1.19% of INVO Fertility at the end of the most recent quarter. Hedge funds and other institutional investors own 12.02% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of INVO Fertility in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

INVO Fertility Stock Performance

NASDAQ IVF traded down $0.01 during trading on Thursday, hitting $0.87. The stock had a trading volume of 52,625 shares, compared to its average volume of 1,028,651. The stock has a market capitalization of $2.09 million, a price-to-earnings ratio of 0.00 and a beta of 2.54. INVO Fertility has a one year low of $0.86 and a one year high of $299.52. The stock has a 50 day simple moving average of $3.14 and a 200 day simple moving average of $10.82.

INVO Fertility Company Profile

INVO Fertility (NASDAQ:IVF) is a medical technology company focused on advancing assisted reproductive treatments through innovative in-vivo incubation solutions. The company develops and commercializes devices designed to facilitate fertilization and early embryo development inside a patient’s body, offering an alternative to conventional laboratory-based in vitro fertilization (IVF) techniques.

The company’s flagship product, the INVOcell device, is a single-use, intravaginal incubator that holds a controlled microenvironment for egg and sperm co-incubation.